ENTA
NASDAQ · Biotechnology
Enanta Pharmaceuticals Inc
$13.77
+0.43 (+3.22%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+223.5% upside
Low Target
$33.16
Average Target
$44.55
High Target
$53.28
Current Price
$13.77
Current
$13.77
$13.77
Target
$44.55
$44.55
$33.16
$44.55 avg
$53.28
Scenario Analysis
Bear Case
$33.16
140.8%
Low target
Base Case
$44.55
+223.5%
Avg target
Bull Case
$53.28
+286.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$17.15
-19.7% from high
52-Week Low
$6.45
+113.5% from low
Target vs 52W High
$44.55
+159.8% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-0.52
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |